Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: D
Results 51 - 60 of 307 shown below

  • degradative enzymes

    E Katerinaki, G S Evans, P C Lorigan and S MacNeil

    TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes

    doi:10.1038/sj.bjc.6601257

  • del(1p)

    C P F Taylor, N P Bown, A G McGuckin, J Lunec, A J Malcolm, A D J Pearson and D Sheer

    Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma

    doi:10.1054/bjoc.2000.1280

  • delay

    V L Allgar and R D Neal

    Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer

    advance online publication, 2005-05-03 00:00:00.000;

    doi:10.1038/sj.bjc.6602587

  • R D Neal and V L Allgar

    Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the 'National Survey of NHS Patients: Cancer'

    advance online publication, 2005-05-17 00:00:00.000;

    doi:10.1038/sj.bjc.6602623

  • S Cold, M Düring, M Ewertz, A Knoop and S Møller

    Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)

    advance online publication, 2005-08-30 00:00:00.000;

    doi:10.1038/sj.bjc.6602734

  • M Pitchers and C Martin

    Delay in referral of oropharyngeal squamous cell carcinoma to secondary care correlates with a more advanced stage at presentation, and is associated with poorer survival

    advance online publication, 2006-03-21 00:00:00.000;

    doi:10.1038/sj.bjc.6603044

  • S Macdonald, U Macleod, N C Campbell, D Weller and E Mitchell

    Systematic review of factors influencing patient and practitioner delay in diagnosis of upper gastrointestinal cancer

    advance online publication, 2006-04-11 00:00:00.000;

    doi:10.1038/sj.bjc.6603089

  • B S Kötz, S Croft and D R Ferry

    Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? a study based on West Midlands cancer registration data

    advance online publication, 2006-09-12 00:00:00.000;

    doi:10.1038/sj.bjc.6603333

  • E Mitchell, S Macdonald, N C Campbell, D Weller and U Macleod

    Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic review

    advance online publication, 2007-12-04 00:00:00.000;

    doi:10.1038/sj.bjc.6604096

  • F Olesen, R P Hansen and P Vedsted

    Delay in diagnosis: the experience in Denmark

    doi:10.1038/sj.bjc.6605383

  • J Austoker, C Bankhead, L J L Forbes, L Atkins, F Martin, K Robb, J Wardle and A J Ramirez

    Interventions to promote cancer awareness and early presentation: systematic review

    doi:10.1038/sj.bjc.6605388

  • U Macleod, E D Mitchell, C Burgess, S Macdonald and A J Ramirez

    Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers

    doi:10.1038/sj.bjc.6605398

  • M A Richards, P Smith, A J Ramirez, I S Fentiman and R D Rubens

    The influence on survival of delay in the presentation and treatment of symptomatic breast cancer

    doi:10.1038/sj.bjc.6690137

  • delayed exposure

    X Ma, P A Buffler, S Selvin, K K Matthay, J K Wiencke, J L Wiemels and P Reynolds

    Daycare attendance and risk of childhood acute lymphoblastic leukaemia

    doi:10.1038/sj.bjc.6600274

  • delayed reproductive death

    N Coen, M A Kadhim, E G Wright, C P Case and C E Mothersill

    Particulate debris from a titanium metal prosthesis induces genomic instability in primary human fibroblast cells

    doi:10.1038/sj.bjc.6600758

  • delayed type hypersensitivity

    M Lotem, T Peretz, O Drize, Z Gimmon, D Ad EL, R Weitzen, H Goldberg, I Ben David, D Prus, T Hamburger and E Shiloni

    Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV)

    doi:10.1038/sj.bjc.6600251

  • delayed type hypersensitivity (DTH)

    A Baars, A M E Claessen, J Wagstaff, G Giaccone, R J Scheper, S Meijer, M J A G Schakel, H E Gall, C J L M Meijer, J B Vermorken, H M Pinedo and A J M van den Eertwegh

    A phase II study of active specific immunotherapy and5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma

    doi:10.1038/sj.bjc.6600254

  • deletion

    N Soufir, J J Lacapere, G Bertrand, E Matichard, R Meziani, D Mirebeau, V Descamps, B Gérard, A Archimbaud, L Ollivaud, F Bouscarat, M Baccard, G Lanternier, P Saïag, C Lebbé, N Basset-Seguin, B Crickx, H Cave and B Grandchamp

    Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma

    doi:10.1038/sj.bjc.6601503

  • G Varma, R Varma, H Huang, A Pryshchepava, J Groth, D Fleming, N J Nowak, D McQuaid, J Conroy, M Mahoney, K Moysich, K L Falkner and J Geradts

    Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York

    advance online publication, 2005-09-13 00:00:00.000;

    doi:10.1038/sj.bjc.6602784

  • N Soufir, B Gerard, M Portela, A Brice, M Liboutet, P Saiag, V Descamps, D Kerob, P Wolkenstein, I Gorin, C Lebbe, N Dupin, B Crickx, N Basset-Seguin and B Grandchamp

    PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study

    doi:10.1038/sj.bjc.6603303

  • R Linger, D Dudakia, R Huddart, D Easton, D T Bishop, M R Stratton and E A Rapley

    A physical analysis of the Y chromosome shows no additional deletions, other than Gr/Gr, associated with testicular germ cell tumour

    advance online publication, 2007-01-09 00:00:00.000;

    doi:10.1038/sj.bjc.6603557

  • I Okamoto, H Pirc-Danoewinata, J Ackermann, J Drach, H Schlagbauer Wadl, B Jansen, K Wolff, H Pehamberger and C Marosi

    Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization

    doi:10.1038/sj.bjc.6690022

  • S-F Chin, Q Wang, A Puisieux and C Caldas

    Absence of rearrangements in the BRCA2 gene in human cancers

    doi:10.1054/bjoc.2000.1577

  • deletion mapping

    A A G van Tilborg, L E Groenfeld, T H van der Kwast and E C Zwarthoff

    Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines

    doi:10.1038/sj.bjc.6690383

  • deletion marker

    A Catteau, C-F Xu, S Hodgson, J Greenman and E Solomon

    Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions

    doi:10.1038/sj.bjc.6690122